Movement Alert｜Thermo Fisher Scientific Rises 3.1% in Regular Trading, High-Level China Meetings Signal Deepening Market Commitment

Market Focus

Aug 20

On August 20, Thermo Fisher Scientific rose 3.1% in regular trading, trading at $632.24/share, with turnover of $454 million. The advance came amid signals of strengthening ties with China, its second-largest global market.

On August 19, Shanghai Mayor Gong Zheng met with Thermo Fisher Chairman and CEO Marc Casper, expressing hope that the company would deepen investment in Shanghai, integrate into the city's biomedical industry ecosystem, and support local biopharma companies in expanding internationally. Casper affirmed plans to increase R&D investment in Shanghai and accelerate global business expansion. Days earlier on August 17, China's Vice Minister of Commerce also met with Thermo Fisher's global president to discuss bilateral trade relations and the company's China development.

The positive diplomatic backdrop adds to broader momentum including strong Q2 results reported July 23, where revenue of $11.99 billion beat estimates by 2.4% and adjusted EPS of $6.03 topped consensus by 5.6%. The company also recently completed the $1.08 billion divestiture of its microbiology business, sharpening its strategic focus on higher-growth segments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1143165003"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143165003\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143165003?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143165003","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Thermo Fisher Scientific Rises 3.1% in Regular Trading, High-Level China Meetings Signal Deepening Market Commitment","media":"Market Focus","content":"<p><p>On August 20, Thermo Fisher Scientific rose 3.1% in regular trading, trading at $632.24/share, with turnover of $454 million. The advance came amid signals of strengthening ties with China, its second-largest global market.</p><p>On August 19, Shanghai Mayor Gong Zheng met with Thermo Fisher Chairman and CEO Marc Casper, expressing hope that the company would deepen investment in Shanghai, integrate into the city's biomedical industry ecosystem, and support local biopharma companies in expanding internationally. Casper affirmed plans to increase R&D investment in Shanghai and accelerate global business expansion. Days earlier on August 17, China's Vice Minister of Commerce also met with Thermo Fisher's global president to discuss bilateral trade relations and the company's China development.</p><p>The positive diplomatic backdrop adds to broader momentum including strong Q2 results reported July 23, where revenue of $11.99 billion beat estimates by 2.4% and adjusted EPS of $6.03 topped consensus by 5.6%. The company also recently completed the $1.08 billion divestiture of its microbiology business, sharpening its strategic focus on higher-growth segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Thermo Fisher Scientific Rises 3.1% in Regular Trading, High-Level China Meetings Signal Deepening Market Commitment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Thermo Fisher Scientific Rises 3.1% in Regular Trading, High-Level China Meetings Signal Deepening Market Commitment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-20 23:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 20, Thermo Fisher Scientific rose 3.1% in regular trading, trading at $632.24/share, with turnover of $454 million. The advance came amid signals of strengthening ties with China, its second-largest global market.</p><p>On August 19, Shanghai Mayor Gong Zheng met with Thermo Fisher Chairman and CEO Marc Casper, expressing hope that the company would deepen investment in Shanghai, integrate into the city's biomedical industry ecosystem, and support local biopharma companies in expanding internationally. Casper affirmed plans to increase R&D investment in Shanghai and accelerate global business expansion. Days earlier on August 17, China's Vice Minister of Commerce also met with Thermo Fisher's global president to discuss bilateral trade relations and the company's China development.</p><p>The positive diplomatic backdrop adds to broader momentum including strong Q2 results reported July 23, where revenue of $11.99 billion beat estimates by 2.4% and adjusted EPS of $6.03 topped consensus by 5.6%. The company also recently completed the $1.08 billion divestiture of its microbiology business, sharpening its strategic focus on higher-growth segments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMO","symbol_name":"赛默飞世尔","start_time":0,"source_url":"","article_id":"1143165003","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143165003","pubTimestamp":1787239211,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 20, Thermo Fisher Scientific rose 3.1% in regular trading, trading at $632.24/share, with turnover of $454 million. The advance came amid signals of strengthening ties with China, its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMO":"赛默飞世尔"},"translate_title":"走势警报|赛默飞世尔科技常规交易上涨3.1%，中国高层会议表明市场承诺加深","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":1},"content_text":"On August 20, Thermo Fisher Scientific rose 3.1% in regular trading, trading at $632.24/share, with turnover of $454 million. The advance came amid signals of strengthening ties with China, its second-largest global market.On August 19, Shanghai Mayor Gong Zheng met with Thermo Fisher Chairman and CEO Marc Casper, expressing hope that the company would deepen investment in Shanghai, integrate into the city's biomedical industry ecosystem, and support local biopharma companies in expanding internationally. Casper affirmed plans to increase R&D investment in Shanghai and accelerate global business expansion. Days earlier on August 17, China's Vice Minister of Commerce also met with Thermo Fisher's global president to discuss bilateral trade relations and the company's China development.The positive diplomatic backdrop adds to broader momentum including strong Q2 results reported July 23, where revenue of $11.99 billion beat estimates by 2.4% and adjusted EPS of $6.03 topped consensus by 5.6%. The company also recently completed the $1.08 billion divestiture of its microbiology business, sharpening its strategic focus on higher-growth segments.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}